Idarucizumab for Dabigatran Reversal.

Journal Club Summary Methodology Score: 2.5/5               Usefulness Score: 3/5   Pollack CV Jr, et al. N Engl J Med. 2015 Aug 6;373(6):511-20 Full Article   This prospective cohort study demonstrated that a new dagbigatran reversal agent, idarucizumab, completely...